@article{12952614b0b84238a76754ee7584d2da,
title = "Association of abdominal visceral adiposity with sputum IL-5 levels in asthma",
author = "{for the HiCARAT investigators} and Houman Goudarzi and Hirokazu Kimura and Hironi Makita and Yuki Abe and Akira Oguma and Michiko Sato and Munehiro Matsumoto and Nozomu Takei and Hiroki Kimura and Kaoruko Shimizu and Masaru Suzuki and Ito, {Yoichi M.} and Masaharu Nishimura and Satoshi Konno",
note = "Funding Information: The Hokkaido-based Investigative Cohort Analysis for Refractory Asthma (Hi-CARAT) Study is supported by the Ministry of Education, Culture, Sports, Science and Technology of Japan (24249049 to M.N., 26461151 to S.K., 17K15843, and 20K10425 to H.G.), and a research grant from AstraZeneca K.K., Kyorin Pharmaceutical Co., Ltd. , and Japan Allergy Foundation during the conduct of the study. Funding Information: This study was approved by the ethics committees of Hokkaido University Hospital and its 29 affiliated hospitals and clinics and was registered in the UMIN Clinical Trials Registry (UMIN-CTR) system (https://upload.umin.ac.jp/cgi-open-bin/ctr/ctr_view.cgi?recptno=R000003917). Details of the study protocol of the Hokkaido-based Investigative Cohort Analysis for Refractory Asthma (HiCARAT). The Hokkaido-based Investigative Cohort Analysis for Refractory Asthma (Hi-CARAT) Study is supported by the Ministry of Education, Culture, Sports, Science and Technology of Japan (24249049 to M.N. 26461151 to S.K. 17K15843, and 20K10425 to H.G.), and a research grant from AstraZeneca K.K. Kyorin Pharmaceutical Co. Ltd., and Japan Allergy Foundation during the conduct of the study. The authors thank the staff and participants who took part in this study.",
year = "2022",
month = jan,
doi = "10.1016/j.alit.2021.08.003",
language = "English (US)",
volume = "71",
pages = "137--139",
journal = "Allergology International",
issn = "1323-8930",
publisher = "Japanese Society of Allergology",
number = "1",
}